Trials / Completed
CompletedNCT02965456
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 820 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP 121 Lotion | IDP-121 lotion will be applied as per the instructions provided by the investigational center staff. |
| DRUG | IDP-121 Vehicle Lotion | IDP-121 vehicle lotion will be applied as per the instructions provided by the investigational center staff. |
Timeline
- Start date
- 2015-11-04
- Primary completion
- 2017-02-23
- Completion
- 2017-02-23
- First posted
- 2016-11-16
- Last updated
- 2019-12-18
- Results posted
- 2019-12-18
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02965456. Inclusion in this directory is not an endorsement.